SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase

This publication has 18 references indexed in Scilit:

• Is there an optimal degree of acid suppression for healing of duodenal ulcers?
  Gastroenterology, 1990
• By 1023/SK&F 96022: Biochemistry of a novel (H+ + K+-ATPase inhibitor
  Biochemical Pharmacology, 1990
• Specific labelling of gastric H+,K+-ATPase by omeprazole
  Biochemical Pharmacology, 1988
• The specificity of omeprazole as an (H++K+)-ATPase inhibitor depends upon the means of its activation
  Biochemical Pharmacology, 1987
• Irreversible inactivation of rat gastric (H+-K+)-ATPase invivo by omeprazole
  Biochemical and Biophysical Research Communications, 1985
• Omeprazole in duodenal ulceration: acid inhibition, symptom relief, endoscopic healing, and recurrence. Cooperative study.
  BMJ, 1984
• Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
  Gut, 1983
• Potassium-stimulated ATPase activity and hydrogen transport in gastric microsomal vesicles
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1979
• Characterization of gastric mucosal membranes. IX. Fractionation and purification of K+-ATPase-containing vesicles by zonal centrifugation and free-flow electrophoresis technique
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1977
• On the reversibility of binding of cardiotonic steroids to a partially purified (Na + K)-activated adenosinetriphosphatase from beef brain
  Biochemical and Biophysical Research Communications, 1970